Diabetic foot therapeutic apparatus

Abstract

The invention discloses a diabetic foot therapeutic apparatus, which relates to the field of medical instruments, solves the problem of poor therapeutic effect of the diabetic foot therapeutic apparatus, and comprises: a data acquisition module, which is used for respectively acquiring the average number ratio of sample bacteria, the pressure coefficient of an affected area, the oxygen enrichment coefficient of the affected area and the area ratio of a foot affected area to obtain affected foot monitoring data, the data analysis module is used for analyzing the sick foot monitoring data to obtain a first treatment control coefficient, a second treatment control coefficient and a third treatment control coefficient, and sick foot treatment analysis data is obtained; the treatment control module is used for controlling the ultraviolet treatment function, the negative pressure treatment function and the oxygen-enriched treatment function of the diabetic foot treatment instrument according to the diseased foot treatment analysis data, the treatment functions are automatically controlled by obtaining the treatment control coefficient, it is ensured that the treatment process is more accurate, the treatment effect is improved, and wound healing is promoted.

Description

Technical Field

[0001] The invention belongs to the field of medical devices and relates to equipment control technology, in particular to a diabetic foot therapeutic device. Background Art

[0002] 1. The existing diabetic foot treatment device has a single treatment method and cannot fully cope with the complex pathological conditions of diabetic foot, resulting in poor treatment effect and slow wound healing;

[0003] 2. The existing diabetic foot treatment device cannot automatically control the treatment function of the diabetic foot treatment device by obtaining the diseased foot monitoring data.

[0004] Therefore, we propose a diabetic foot treatment device. Summary of the invention

[0005] In view of the shortcomings of the prior art, the purpose of the present invention is to provide a diabetic foot treatment device. The present invention obtains diseased foot monitoring data based on the average sample bacteria count ratio, the affected area pressure coefficient, the affected area oxygen enrichment coefficient and the area ratio of the diseased area of ​​the foot, and obtains a first treatment control coefficient, a second treatment control coefficient and a third treatment control coefficient by analyzing the diseased foot monitoring data, and obtains diseased foot treatment analysis data. According to the diseased foot treatment analysis data, the ultraviolet treatment function, negative pressure treatment function and oxygen enrichment treatment function of the diabetic foot treatment device are controlled respectively.

[0006] In order to achieve the above-mentioned purpose, the present invention adopts the following technical scheme: The specific working process of each module of a diabetic foot treatment device is as follows:

[0007] Data acquisition module: used to obtain the average number ratio of sample bacteria, the pressure coefficient of the affected area, the oxygen enrichment coefficient of the affected area and the area ratio of the affected area of ​​the foot, and obtain the diseased foot monitoring data;

[0008] Data analysis module: used to obtain the first treatment control coefficient, the second treatment control coefficient and the third treatment control coefficient by analyzing the diseased foot monitoring data, and obtain the diseased foot treatment analysis data;

[0009] Treatment control module: used to control the ultraviolet treatment function, negative pressure treatment function and oxygen enrichment treatment function of the diabetic foot treatment device according to the diseased foot treatment analysis data.

[0010] Furthermore, the data acquisition module acquires the diseased foot monitoring data as follows:

[0011] The bacterial types of the patients' feet were analyzed to obtain the average bacterial count ratio of the samples;

[0012] Perform pressure analysis on the patient's foot to obtain the pressure coefficient of the affected area;

[0013] Analyze the oxygen content in the affected area of ​​the patient's foot to obtain the oxygen enrichment coefficient of the affected area;

[0014] The diseased area of ​​the patient's foot is analyzed to obtain the area ratio of the diseased area of ​​the foot;

[0015] The average number ratio of bacteria in the samples, the pressure coefficient of the affected area, the oxygen enrichment coefficient of the affected area and the area ratio of the diseased area of ​​the foot were defined as the diseased foot monitoring data.

[0016] Furthermore, the data acquisition module acquires the average number ratio of bacteria in the sample, as follows:

[0017] When the patient's foot is inserted into the therapeutic device, the therapeutic device collects the epidermal exfoliated material of the patient's foot at intervals of a characteristic time to obtain a sample of the patient's foot tissue, and obtains the quality of the sample of the patient's foot tissue to obtain a sample tissue quality value;

[0018] Obtain the bacterial count value of the first sample to the bacterial count value of the nth sample;

[0019] The average bacterial quantity ratio of the samples is obtained by calculating the bacterial quantity value of the first sample to the bacterial quantity value of the nth sample and the sample tissue mass value;

[0020] The average bacterial count ratio of the samples was calculated.

[0021] Furthermore, the data acquisition module acquires the bacterial count values ​​of the first sample to the bacterial count values ​​of the nth sample, as follows:

[0022] Mark n different types of sample monitoring bacteria in the foot tissue samples collected from the patient, and name them as the first type of sample bacteria to the nth type of sample bacteria, respectively;

[0023] Bacteria monitoring is performed on samples collected from the patient's foot tissue, and the number values ​​corresponding to the first type of sample bacteria to the nth type of sample bacteria in the patient's foot tissue sample are obtained respectively, so as to obtain the first sample bacteria number value to the nth sample bacteria number value.

[0024] Furthermore, the data acquisition module acquires the pressure coefficient of the affected area as follows:

[0025] Mark a pressure monitoring points on the ulcer of the patient's foot and name them as the first pressure monitoring point to the ath pressure monitoring point respectively;

[0026] Acquire the pressure values ​​corresponding to the first pressure monitoring point to the ath pressure monitoring point through the first data acquisition device to obtain the first pressure value to the ath pressure value;

[0027] Calculate the average of the first pressure value to the ath pressure value to obtain the average pressure value of the affected area;

[0028] Calculate the variance of the first pressure value to the ath pressure value to obtain the pressure variance of the monitoring point;

[0029] Obtaining a preset baseline pressure value of the affected area;

[0030] The pressure coefficient of the affected area is obtained by calculating the preset reference pressure value of the affected area, the average pressure value of the affected area and the pressure variance of the monitoring point;

[0031] Calculate the pressure coefficient of the affected area.

[0032] Furthermore, the data acquisition module acquires the oxygen enrichment coefficient of the affected area, as follows:

[0033] Mark multiple temperature monitoring points on the patient's foot, acquire the temperature value corresponding to each temperature monitoring point in real time through a second data acquisition device, obtain the real-time temperature values ​​of multiple monitoring points, and average the real-time temperature values ​​of multiple monitoring points to obtain the average temperature value of the affected foot;

[0034] Extract a blood oxygen sample from the affected area of ​​the patient's foot, obtain the blood oxygen content of the blood sample, and obtain the blood oxygen content value of the affected area;

[0035] Using a third data acquisition device to acquire the humidity value of the affected area of ​​the patient's foot, to obtain the humidity value of the affected area;

[0036] The oxygen enrichment coefficient of the affected area is obtained by calculating the humidity value of the affected area, the average temperature value of the affected foot and the blood oxygen content value of the affected area;

[0037] Calculate the oxygen enrichment coefficient of the affected area.

[0038] Furthermore, the data acquisition module acquires the area ratio of the diseased area of ​​the foot, as follows:

[0039] Acquire a patient's foot image, mark the edge of the patient's foot in the patient's foot image to obtain a first marked area, and mark the edge of the diseased area in the patient's foot image to obtain a first marked area;

[0040] The first marked area and the second marked area are filled with pixels respectively, the number of pixels covered by the first marked area is obtained to obtain a first pixel number value, the number of pixels covered by the second marked area is obtained to obtain a second pixel number value, and the ratio of the first pixel number value to the second pixel number value is calculated to obtain the area ratio of the diseased area of ​​the foot.

[0041] Furthermore, the data analysis module acquires the diseased foot treatment analysis data as follows:

[0042] Obtain diseased foot monitoring data, and obtain the average number ratio of sample bacteria, the pressure coefficient of the affected area, the oxygen enrichment coefficient of the affected area, and the area ratio of the affected area of ​​the foot according to the diseased foot monitoring data;

[0043] The first treatment control coefficient is obtained by calculating the ratio of the average number of bacteria in the samples and the ratio of the area of ​​the diseased area of ​​the foot;

[0044] Calculating the first treatment control coefficient;

[0045] The second treatment control coefficient is obtained by calculating the pressure coefficient of the affected area and the area ratio of the affected area of ​​the foot;

[0046] Calculating the second treatment control coefficient;

[0047] The third treatment control coefficient is obtained by calculating the oxygen enrichment coefficient of the affected area and the area ratio of the affected area of ​​the foot;

[0048] Calculate the third treatment control coefficient;

[0049] The first treatment control coefficient, the second treatment control coefficient and the third treatment control coefficient are defined as diseased foot treatment analysis data.

[0050] Furthermore, the treatment control module performs automatic control on the diabetic foot treatment device, as follows:

[0051] Acquire diseased foot treatment analysis data, and acquire a first treatment control coefficient, a second treatment control coefficient, and a third treatment control coefficient according to the diseased foot treatment analysis data;

[0052] respectively obtaining a first treatment control coefficient threshold, a second treatment control coefficient threshold, and a third treatment control coefficient threshold;

[0053] The first treatment control coefficient threshold, the second treatment control coefficient threshold and the third treatment control coefficient threshold are numerically compared with the first treatment control coefficient, the second treatment control coefficient and the third treatment control coefficient respectively, and the diabetic foot treatment device is automatically controlled according to the numerical comparison results.

[0054] Furthermore, the numerical comparison process is as follows:

[0055] When the first treatment control coefficient is greater than or equal to the first treatment control coefficient threshold, the diabetic foot treatment instrument is controlled to start the ultraviolet treatment function;

[0056] When the first treatment control coefficient is less than the first treatment control coefficient threshold, the diabetic foot treatment instrument is controlled to turn off the ultraviolet treatment function;

[0057] When the second treatment control coefficient is greater than or equal to the second treatment control coefficient threshold, the diabetic foot treatment instrument is controlled to start the negative pressure treatment function;

[0058] When the second treatment control coefficient is less than the second treatment control coefficient threshold, the diabetic foot treatment instrument is controlled to turn off the negative pressure treatment function;

[0059] When the third treatment control coefficient is greater than or equal to the third treatment control coefficient threshold, the diabetic foot treatment instrument is controlled to start the oxygen enrichment treatment function;

[0060] When the third treatment control coefficient is less than the third treatment control coefficient threshold, the diabetic foot treatment instrument is controlled to turn off the oxygen enrichment treatment function.

[0061] In summary, due to the adoption of the above technical solution, the beneficial effects of the present invention are:

[0062] 1. The present invention can simultaneously perform ultraviolet therapy, negative pressure therapy and oxygen enrichment therapy on the affected area of ​​the patient's foot, which can more comprehensively cope with the complex pathological conditions of diabetic foot, improve the treatment effect and promote wound healing;

[0063] 2. The present invention automatically controls the treatment function by obtaining the treatment control coefficient, thereby ensuring a more accurate treatment process, improving the treatment effect, and promoting wound healing. BRIEF DESCRIPTION OF THE DRAWINGS

[0064] In order to facilitate understanding by those skilled in the art, the present invention is further described below with reference to the accompanying drawings.

[0065] Figure 1 is the overall system block diagram of the present invention;

[0066] Figure 2 It is a diagram of the implementation steps of the present invention;

[0067] Figure 3 It is a schematic diagram of the diabetic foot therapeutic device of the present invention. DETAILED DESCRIPTION

[0068] The technical solution of the present invention will be clearly and completely described below in conjunction with the embodiments. Obviously, the described embodiments are only part of the embodiments of the present invention, not all of the embodiments. Based on the embodiments of the present invention, all other embodiments obtained by ordinary technicians in this field without creative work are within the scope of protection of the present invention.

[0069] Embodiment 1

[0070] See also Figure 1, the present invention provides a technical solution: a diabetic foot treatment instrument, comprising a data acquisition module, a data analysis module, a diseased foot treatment module and a server, wherein the data acquisition module, the data analysis module and the diseased foot treatment module are respectively connected to the server, and the server controls the data acquisition module, the data analysis module and the diseased foot treatment module respectively;

[0071] The data acquisition module obtains the average number ratio of sample bacteria, the pressure coefficient of the affected area, the oxygen enrichment coefficient of the affected area, and the area ratio of the affected area of ​​the foot to obtain the diseased foot monitoring data;

[0072] The bacterial types of the patients' feet were analyzed to obtain the average bacterial count ratio of the samples;

[0073] The details are as follows:

[0074] When the patient's foot is inserted into the therapeutic device, the therapeutic device collects the epidermal exfoliated material of the patient's foot at intervals of a characteristic time to obtain a sample of the patient's foot tissue, and obtains the quality of the sample of the patient's foot tissue to obtain a sample tissue quality value;

[0075] It should be noted here that:

[0076] The exfoliated substances on the patient's feet involved here include but are not limited to skin keratin, pus and blood;

[0077] The characteristic duration involved here is specifically 3 minutes;

[0078] Mark n different types of sample monitoring bacteria in the foot tissue samples collected from the patient, and name them as the first type of sample bacteria to the nth type of sample bacteria, respectively;

[0079] It should be noted here that:

[0080] In this application, n is the number value corresponding to the bacteria monitored in the sample, and n is an integer greater than 0;

[0081] In the present application, the first type of sample bacteria may be Candida albicans, the second type of sample bacteria may be dermatophytes, the third type of sample bacteria may be Aspergillus, and the nth type of sample bacteria may be Penicillium;

[0082] Performing bacterial monitoring on samples collected from the patient's foot tissue respectively, obtaining the number values ​​corresponding to the first type of sample bacteria to the nth type of sample bacteria in the samples collected from the patient's foot tissue respectively, and obtaining the first sample bacteria number value to the nth sample bacteria number value;

[0083] The average bacterial quantity ratio of the samples is obtained by calculating the bacterial quantity value of the first sample to the bacterial quantity value of the nth sample and the sample tissue mass value;

[0084] The average number ratio of sample bacteria is calculated, and the specific formula is configured as follows:

[0085]

[0086] Among them, Xjp is the average number ratio of sample bacteria, Ls1 to Lsn are the number of bacteria in the first sample to the number of bacteria in the nth sample, Yzz is the sample tissue quality value, and n is the number value corresponding to the sample monitoring bacteria;

[0087] Perform pressure analysis on the patient's foot to obtain the pressure coefficient of the affected area;

[0088] The details are as follows:

[0089] Mark a pressure monitoring points on the ulcer of the patient's foot and name them as the first pressure monitoring point to the ath pressure monitoring point respectively;

[0090] It should be noted here that:

[0091] In this application, a is the quantity value corresponding to the pressure monitoring point, and a is an integer greater than 0;

[0092] Acquire the pressure values ​​corresponding to the first pressure monitoring point to the ath pressure monitoring point through the first data acquisition device to obtain the first pressure value to the ath pressure value;

[0093] Calculate the average of the first pressure value to the ath pressure value to obtain the average pressure value of the affected area;

[0094] Calculate the variance of the first pressure value to the ath pressure value to obtain the pressure variance of the monitoring point;

[0095] Obtaining a preset baseline pressure value of the affected area;

[0096] It should be noted here that:

[0097] The preset baseline pressure value of the affected area involved herein is specifically a pressure reference value or standard value set for a specific affected area, which is determined based on a variety of factors, including but not limited to the physiological characteristics of the affected area, treatment needs, and safety standards;

[0098] The first data acquisition device involved here is an intelligent pressure monitor;

[0099] The pressure coefficient of the affected area is obtained by calculating the preset reference pressure value of the affected area, the average pressure value of the affected area and the pressure variance of the monitoring point;

[0100] The pressure coefficient of the affected area is calculated using the following formula:

[0101] Hyx=|Hpy-Hjy|×Yjc;

[0102] Among them, Hyx is the pressure coefficient of the affected area, Hpy is the average pressure value of the affected area, Hjy is the preset reference pressure value of the affected area, and Yjc is the average pressure value of the affected area;

[0103] Analyze the oxygen content in the affected area of ​​the patient's foot to obtain the oxygen enrichment coefficient of the affected area;

[0104] The details are as follows:

[0105] Mark multiple temperature monitoring points on the patient's foot, acquire the temperature value corresponding to each temperature monitoring point in real time through a second data acquisition device, obtain the real-time temperature values ​​of multiple monitoring points, and average the real-time temperature values ​​of multiple monitoring points to obtain the average temperature value of the affected foot;

[0106] Extract a blood oxygen sample from the affected area of ​​the patient's foot, obtain the blood oxygen content of the blood sample, and obtain the blood oxygen content value of the affected area;

[0107] Using a third data acquisition device to acquire the humidity value of the affected area of ​​the patient's foot, to obtain the humidity value of the affected area;

[0108] It should be noted here that:

[0109] In the present application, the second data acquisition device is a temperature sensor, and the third data acquisition device is a humidity sensor;

[0110] The oxygen enrichment coefficient of the affected area is obtained by calculating the humidity value of the affected area, the average temperature value of the affected foot and the blood oxygen content value of the affected area;

[0111] The oxygen enrichment coefficient of the affected area is calculated using the following formula:

[0112]

[0113] Among them, Fyx is the oxygen enrichment coefficient of the affected area, Qyq is the blood oxygen content value of the affected area, Shd is the humidity value of the affected area, and Txy is the average temperature value of the affected foot;

[0114] The diseased area of ​​the patient's foot is analyzed to obtain the area ratio of the diseased area of ​​the foot;

[0115] Acquire a patient's foot image, mark the edge of the patient's foot in the patient's foot image to obtain a first marked area, and mark the edge of the diseased area in the patient's foot image to obtain a first marked area;

[0116] It should be noted here that:

[0117] The diseased area involved here is specifically the ulcerated area;

[0118] Filling pixels in the first marked area and the second marked area respectively, acquiring the number of pixels covered in the first marked area to obtain a first pixel number value, acquiring the number of pixels covered in the second marked area to obtain a second pixel number value, calculating the ratio of the first pixel number value to the second pixel number value, and obtaining the area ratio of the diseased area of ​​the foot;

[0119] The average number ratio of bacteria in the samples, the pressure coefficient of the affected area, the oxygen enrichment coefficient of the affected area, and the area ratio of the affected area of ​​the foot were defined as the diseased foot monitoring data;

[0120] The data acquisition module acquires the diseased foot monitoring data and transmits it to the data analysis module;

[0121] The data analysis module obtains the first treatment control coefficient, the second treatment control coefficient and the third treatment control coefficient by analyzing the diseased foot monitoring data, and obtains the diseased foot treatment analysis data;

[0122] Obtain diseased foot monitoring data, and obtain the average number ratio of sample bacteria, the pressure coefficient of the affected area, the oxygen enrichment coefficient of the affected area, and the area ratio of the affected area of ​​the foot according to the diseased foot monitoring data;

[0123] The first treatment control coefficient is obtained by calculating the ratio of the average number of bacteria in the samples and the ratio of the area of ​​the diseased area of ​​the foot;

[0124] The first treatment control coefficient is calculated, and the specific formula is as follows:

[0125] Kzx1=Xjp+Mjb×a1;

[0126] Among them, Kzx1 is the first treatment control coefficient, Xjp is the average number ratio of sample bacteria, Mjb is the area ratio of the diseased area of ​​the foot, a1 is the set proportional coefficient, and a1 is greater than 0;

[0127] The second treatment control coefficient is obtained by calculating the pressure coefficient of the affected area and the area ratio of the affected area of ​​the foot;

[0128] The second treatment control coefficient is calculated as follows:

[0129] Kzx2=Hyx+Mjb×a2;

[0130] Wherein, Kzx2 is the second treatment control coefficient, Hyx is the pressure coefficient of the affected area, Mjb is the area ratio of the affected area of ​​the foot, a2 is the set proportional coefficient, and a2 is greater than 0;

[0131] The third treatment control coefficient is obtained by calculating the oxygen enrichment coefficient of the affected area and the area ratio of the affected area of ​​the foot;

[0132] The third treatment control coefficient is calculated, and the specific formula is as follows:

[0133] Kzx3=Fyx+Mjb×a3;

[0134] Among them, Kzx3 is the third treatment control coefficient, Fyx is the oxygen enrichment coefficient of the affected area, Mjb is the area ratio of the affected area of ​​the foot, a3 is the set proportional coefficient, and a3 is greater than 0;

[0135] The first treatment control coefficient, the second treatment control coefficient and the third treatment control coefficient are defined as diseased foot treatment analysis data;

[0136] The data analysis module acquires the sick foot treatment analysis data and transmits it to the sick foot treatment module;

[0137] The treatment control module performs automatic equipment control on the diabetic foot treatment device according to the diseased foot treatment analysis data;

[0138] Acquire diseased foot treatment analysis data, and acquire a first treatment control coefficient, a second treatment control coefficient, and a third treatment control coefficient according to the diseased foot treatment analysis data;

[0139] respectively obtaining a first treatment control coefficient threshold, a second treatment control coefficient threshold, and a third treatment control coefficient threshold;

[0140] It should be noted here that:

[0141] The first treatment control coefficient threshold, the second treatment control coefficient threshold and the third treatment control coefficient threshold involved here can be specifically set according to the actual situation of the patient;

[0142] See also Figure 3 , numerically comparing the first treatment control coefficient threshold, the second treatment control coefficient threshold and the third treatment control coefficient threshold with the first treatment control coefficient, the second treatment control coefficient and the third treatment control coefficient, respectively, and automatically controlling the diabetic foot therapeutic apparatus according to the numerical comparison results;

[0143] The details are as follows:

[0144] When the first treatment control coefficient is greater than or equal to the first treatment control coefficient threshold, the diabetic foot treatment instrument is controlled to start the ultraviolet treatment function;

[0145] When the first treatment control coefficient is less than the first treatment control coefficient threshold, the diabetic foot treatment instrument is controlled to turn off the ultraviolet treatment function;

[0146] When the second treatment control coefficient is greater than or equal to the second treatment control coefficient threshold, the diabetic foot treatment instrument is controlled to start the negative pressure treatment function;

[0147] When the second treatment control coefficient is less than the second treatment control coefficient threshold, the diabetic foot treatment instrument is controlled to turn off the negative pressure treatment function;

[0148] When the third treatment control coefficient is greater than or equal to the third treatment control coefficient threshold, the diabetic foot treatment instrument is controlled to start the oxygen enrichment treatment function;

[0149] When the third treatment control coefficient is less than the third treatment control coefficient threshold, the diabetic foot treatment instrument is controlled to turn off the oxygen enrichment treatment function;

[0150] It should be noted here that:

[0151] In this application, the ultraviolet therapy function, negative pressure therapy function, and oxygen-enriched therapy function can be turned on at the same time;

[0152] The preferred embodiments of the present invention disclosed above are only used to help illustrate the present invention.

[0153] In this application, if corresponding calculation formulas appear, the above calculation formulas are all dimensionless and take their numerical calculations. The weight coefficients, proportional coefficients and other coefficients in the formulas are set to a result value obtained by quantifying each parameter. The size of the weight coefficient and the proportional coefficient can be determined as long as it does not affect the proportional relationship between the parameter and the result value.

[0154] Embodiment 2

[0155] See also Figure 2 Based on another concept of the same invention, a diabetic foot treatment method is now proposed for application in a diabetic treatment apparatus, and the diabetic treatment method includes the following specific steps:

[0156] Step S1: respectively obtaining the average number ratio of sample bacteria, the pressure coefficient of the affected area, the oxygen enrichment coefficient of the affected area, and the area ratio of the affected area of ​​the foot to obtain the diseased foot monitoring data;

[0157] Step S11: Analyze the bacterial types on the patient's feet to obtain the average bacterial count ratio of the samples;

[0158] The details are as follows:

[0159] Step S111: When the patient's foot is inserted into the therapeutic device, the therapeutic device collects epidermal exfoliated material from the patient's foot at intervals of a characteristic time to obtain a sample of the patient's foot tissue, and acquires the mass of the sample of the patient's foot tissue to obtain a sample tissue mass value;

[0160] Step S112: marking n different types of sample monitoring bacteria in the foot tissue samples collected from the patient, and naming them as first type sample bacteria to nth type sample bacteria respectively;

[0161] Step S113: performing bacterial monitoring on the samples collected from the patient's foot tissue respectively, obtaining the number values ​​corresponding to the first type of sample bacteria to the nth type of sample bacteria in the samples collected from the patient's foot tissue respectively, and obtaining the first sample bacteria number value to the nth sample bacteria number value;

[0162] Step S114: Calculate the bacterial count value of the first sample to the bacterial count value of the nth sample and the sample tissue mass value to obtain the average bacterial count ratio of the samples;

[0163] The average number ratio of sample bacteria is calculated, and the specific formula is configured as follows:

[0164]

[0165] Among them, Xjp is the average number ratio of sample bacteria, Ls1 to Lsn are the number of bacteria in the first sample to the number of bacteria in the nth sample, Yzz is the sample tissue quality value, and n is the number value corresponding to the sample monitoring bacteria;

[0166] Step S12: performing pressure analysis on the patient's foot to obtain a pressure coefficient of the affected area;

[0167] The details are as follows:

[0168] Step S121: marking a pressure monitoring points at the ulceration site on the patient's foot, and naming them as the first pressure monitoring point to the ath pressure monitoring point;

[0169] Step S122: acquiring pressure values ​​corresponding to the first pressure monitoring point to the ath pressure monitoring point respectively through the first data acquisition device, and obtaining the first pressure value to the ath pressure value;

[0170] Step S123: Calculate the average of the first pressure value to the ath pressure value to obtain the average pressure value of the affected area;

[0171] Step S124: Calculate the variance of the first pressure value to the ath pressure value to obtain the pressure variance of the monitoring point;

[0172] Step S125: obtaining a preset reference pressure value of the affected area;

[0173] Step S126: Calculate the preset reference pressure value of the affected area, the average pressure value of the affected area, and the pressure variance of the monitoring point to obtain the pressure coefficient of the affected area;

[0174] The pressure coefficient of the affected area is calculated using the following formula:

[0175] Hyx=|Hpy-Hjy|×Yjc;

[0176] Among them, Hyx is the pressure coefficient of the affected area, Hpy is the average pressure value of the affected area, Hjy is the preset reference pressure value of the affected area, and Yjc is the average pressure value of the affected area;

[0177] Step S13: Analyze the oxygen content of the affected area of ​​the patient's foot to obtain the oxygen enrichment coefficient of the affected area;

[0178] The details are as follows:

[0179] Step S131: marking a plurality of temperature monitoring points on the patient's foot, acquiring the temperature value corresponding to each temperature monitoring point in real time through a second data acquisition device, obtaining the real-time temperature values ​​of the plurality of monitoring points, and averaging the real-time temperature values ​​of the plurality of monitoring points to obtain the average temperature value of the affected foot;

[0180] Step S132: extracting a blood oxygen sample from the affected area of ​​the patient's foot, and acquiring the blood oxygen content of the blood sample to obtain a blood oxygen content value of the affected area;

[0181] Step S133: using a third data acquisition device to acquire the humidity value of the affected area of ​​the patient's foot to obtain the humidity value of the affected area;

[0182] Step S134: calculating the oxygen enrichment coefficient of the affected area by using the humidity value of the affected area, the average temperature value of the affected foot, and the blood oxygen content value of the affected area;

[0183] The oxygen enrichment coefficient of the affected area is calculated using the following formula:

[0184]

[0185] Among them, Fyx is the oxygen enrichment coefficient of the affected area, Qyq is the blood oxygen content value of the affected area, Shd is the humidity value of the affected area, and Txy is the average temperature value of the affected foot;

[0186] Step S14: analyzing the diseased area of ​​the patient's foot to obtain the area ratio of the diseased area of ​​the foot;

[0187] The details are as follows:

[0188] Step S141: acquiring a patient's foot image, marking the edge of the patient's foot in the patient's foot image to obtain a first marked area, marking the edge of the diseased area in the patient's foot image to obtain a first marked area;

[0189] Step S142: Fill the first marked area and the second marked area with pixels respectively, obtain the number of pixels covered by the first marked area to obtain a first pixel number value, obtain the number of pixels covered by the second marked area to obtain a second pixel number value, calculate the ratio of the first pixel number value to the second pixel number value, and obtain the area ratio of the diseased area of ​​the foot;

[0190] Step S15: defining the average number ratio of sample bacteria, the pressure coefficient of the affected area, the oxygen enrichment coefficient of the affected area, and the area ratio of the affected area of ​​the foot as the diseased foot monitoring data;

[0191] Step S2: obtaining a first treatment control coefficient, a second treatment control coefficient and a third treatment control coefficient by analyzing the diseased foot monitoring data, and obtaining diseased foot treatment analysis data;

[0192] Step S21: Acquire diseased foot monitoring data, and acquire the average number ratio of sample bacteria, the pressure coefficient of the affected area, the oxygen enrichment coefficient of the affected area, and the area ratio of the affected area of ​​the foot according to the diseased foot monitoring data;

[0193] Step S22: obtaining a first treatment control coefficient by calculating the average number ratio of bacteria in the samples and the area ratio of the diseased area of ​​the foot;

[0194] The first treatment control coefficient is calculated, and the specific formula is as follows:

[0195] Kzx1=Xjp+Mjb×a1;

[0196] Among them, Kzx1 is the first treatment control coefficient, Xjp is the average number ratio of sample bacteria, Mjb is the area ratio of the diseased area of ​​the foot, a1 is the set proportional coefficient, and a1 is greater than 0;

[0197] Step S23: obtaining a second treatment control coefficient by calculating the pressure coefficient of the affected area and the area ratio of the affected area of ​​the foot;

[0198] The second treatment control coefficient is calculated as follows:

[0199] Kzx2=Hyx+Mjb×a2;

[0200] Wherein, Kzx2 is the second treatment control coefficient, Hyx is the pressure coefficient of the affected area, Mjb is the area ratio of the affected area of ​​the foot, a2 is the set proportional coefficient, and a2 is greater than 0;

[0201] Step S24: obtaining a third treatment control coefficient by calculating the oxygen enrichment coefficient of the affected area and the area ratio of the affected area of ​​the foot;

[0202] The third treatment control coefficient is calculated, and the specific formula is as follows:

[0203] Kzx3=Fyx+Mjb×a3;

[0204] Among them, Kzx3 is the third treatment control coefficient, Fyx is the oxygen enrichment coefficient of the affected area, Mjb is the area ratio of the affected area of ​​the foot, a3 is the set proportional coefficient, and a3 is greater than 0;

[0205] Step S25: defining the first treatment control coefficient, the second treatment control coefficient and the third treatment control coefficient as diseased foot treatment analysis data;

[0206] Step S3: Automated equipment control of the diabetic foot treatment instrument according to the diseased foot treatment analysis data;

[0207] Step S31: Acquire diseased foot treatment analysis data, and acquire a first treatment control coefficient, a second treatment control coefficient, and a third treatment control coefficient according to the diseased foot treatment analysis data;

[0208] Step S32: respectively obtaining a first treatment control coefficient threshold, a second treatment control coefficient threshold, and a third treatment control coefficient threshold;

[0209] Step S33: numerically comparing the first treatment control coefficient threshold, the second treatment control coefficient threshold and the third treatment control coefficient threshold with the first treatment control coefficient, the second treatment control coefficient and the third treatment control coefficient, respectively, and automatically controlling the diabetic foot therapeutic apparatus according to the numerical comparison results;

[0210] The details are as follows:

[0211] Step S331: when the first treatment control coefficient is greater than or equal to the first treatment control coefficient threshold, controlling the diabetic foot treatment instrument to start the ultraviolet treatment function;

[0212] Step S332: when the first treatment control coefficient is less than the first treatment control coefficient threshold, controlling the diabetic foot treatment instrument to turn off the ultraviolet treatment function;

[0213] Step S333: when the second treatment control coefficient is greater than or equal to the second treatment control coefficient threshold, controlling the diabetic foot treatment instrument to start the negative pressure treatment function;

[0214] Step S334: when the second treatment control coefficient is less than the second treatment control coefficient threshold, controlling the diabetic foot treatment instrument to turn off the negative pressure treatment function;

[0215] Step S335: when the third treatment control coefficient is greater than or equal to the third treatment control coefficient threshold, controlling the diabetic foot treatment instrument to start the oxygen enrichment treatment function;

[0216] Step S336: When the third treatment control coefficient is less than the third treatment control coefficient threshold, the diabetic foot treatment apparatus is controlled to turn off the oxygen enrichment treatment function.

[0217] The preferred embodiments do not describe all the details in detail, nor do they limit the invention to specific implementation methods. Obviously, many modifications and changes can be made according to the content of this specification. This specification selects and specifically describes these embodiments in order to better explain the principles and practical applications of the present invention, so that those skilled in the art can understand and use the present invention well. The present invention is limited only by the claims and their full scope and equivalents.

Claims

1. A diabetic foot treatment device, characterized in that: include: Data acquisition module: used to obtain the average number ratio of sample bacteria, the pressure coefficient of the affected area, the oxygen enrichment coefficient of the affected area and the area ratio of the affected area of ​​the foot, and obtain the diseased foot monitoring data; Data analysis module: used to obtain the first treatment control coefficient, the second treatment control coefficient and the third treatment control coefficient by analyzing the diseased foot monitoring data, and obtain the diseased foot treatment analysis data; Treatment control module: used to control the ultraviolet treatment function, negative pressure treatment function and oxygen enrichment treatment function of the diabetic foot treatment device according to the diseased foot treatment analysis data.

2. A diabetic foot treatment device according to claim 1, characterized in that: The data acquisition module acquires the diseased foot monitoring data, specifically as follows: The bacterial types of the patients' feet were analyzed to obtain the average bacterial count ratio of the samples; Perform pressure analysis on the patient's foot to obtain the pressure coefficient of the affected area; Analyze the oxygen content in the affected area of ​​the patient's foot to obtain the oxygen enrichment coefficient of the affected area; The diseased area of ​​the patient's foot is analyzed to obtain the area ratio of the diseased area of ​​the foot; The average number ratio of bacteria in the samples, the pressure coefficient of the affected area, the oxygen enrichment coefficient of the affected area and the area ratio of the diseased area of ​​the foot were defined as the diseased foot monitoring data.

3. A diabetic foot treatment device according to claim 2, characterized in that: The data acquisition module acquires the average number ratio of bacteria in the sample, as follows: When the patient's foot is inserted into the therapeutic device, the therapeutic device collects the epidermal exfoliated material of the patient's foot at intervals of a characteristic time to obtain a sample of the patient's foot tissue, and obtains the quality of the sample of the patient's foot tissue to obtain a sample tissue quality value; Obtain the bacterial count value of the first sample to the bacterial count value of the nth sample; The average bacterial quantity ratio of the samples is obtained by calculating the bacterial quantity value of the first sample to the bacterial quantity value of the nth sample and the sample tissue mass value; The average bacterial count ratio of the samples was calculated.

4. A diabetic foot treatment device according to claim 3, characterized in that: The data acquisition module acquires the bacterial count values ​​of the first sample to the bacterial count values ​​of the nth sample, as follows: Marking n different types of sample monitoring bacteria in the foot tissue collection samples of the patient, and naming them as the first type of sample bacteria to the nth type of sample bacteria respectively; By performing bacterial monitoring on samples collected from the patient's foot tissue, the number values ​​corresponding to the first type of sample bacteria to the nth type of sample bacteria in the samples collected from the patient's foot tissue are obtained, and the first sample bacteria number value to the nth sample bacteria number value are obtained.

5. A diabetic foot treatment device according to claim 2, characterized in that: The data acquisition module acquires the pressure coefficient of the affected area, specifically as follows: Mark a pressure monitoring points on the ulcer of the patient's foot and name them as the first pressure monitoring point to the ath pressure monitoring point respectively; Obtain the pressure values ​​corresponding to the first pressure monitoring point to the ath pressure monitoring point, and obtain the first pressure value to the ath pressure value; Calculate the average of the first pressure value to the ath pressure value to obtain the average pressure value of the affected area; Calculate the variance of the first pressure value to the ath pressure value to obtain the pressure variance of the monitoring point; Obtaining a preset baseline pressure value of the affected area; The pressure coefficient of the affected area is obtained by calculating the preset reference pressure value of the affected area, the average pressure value of the affected area and the pressure variance of the monitoring point; Calculate the pressure coefficient of the affected area.

6. A diabetic foot treatment device according to claim 2, characterized in that: The data acquisition module acquires the oxygen enrichment coefficient of the affected area, as follows: Mark multiple temperature monitoring points on the patient's foot, obtain the temperature value corresponding to each temperature monitoring point in real time, obtain the real-time temperature values ​​of multiple monitoring points, and average the real-time temperature values ​​of multiple monitoring points to obtain the average temperature value of the affected foot; Extract a blood oxygen sample from the affected area of ​​the patient's foot, obtain the blood oxygen content of the blood sample, and obtain the blood oxygen content value of the affected area; The humidity value of the affected area of ​​the patient's foot is obtained to obtain the humidity value of the affected area; The oxygen enrichment coefficient of the affected area is obtained by calculating the humidity value of the affected area, the average temperature value of the affected foot and the blood oxygen content value of the affected area; Calculate the oxygen enrichment coefficient of the affected area.

7. A diabetic foot treatment device according to claim 2, characterized in that: The data acquisition module acquires the area ratio of the diseased area of ​​the foot, specifically as follows: Acquire a patient's foot image, mark the edge of the patient's foot in the patient's foot image to obtain a first marked area, and mark the edge of the diseased area in the patient's foot image to obtain a first marked area; The first marked area and the second marked area are filled with pixels respectively, the number of pixels covered by the first marked area is obtained to obtain a first pixel number value, the number of pixels covered by the second marked area is obtained to obtain a second pixel number value, and the ratio of the first pixel number value to the second pixel number value is calculated to obtain the area ratio of the diseased area of ​​the foot.

8. The diabetic foot treatment device according to claim 1, characterized in that: The data analysis module acquires the diseased foot treatment analysis data, specifically as follows: Obtain diseased foot monitoring data, and obtain the average number ratio of sample bacteria, the pressure coefficient of the affected area, the oxygen enrichment coefficient of the affected area, and the area ratio of the affected area of ​​the foot according to the diseased foot monitoring data; The first treatment control coefficient is obtained by calculating the ratio of the average number of bacteria in the samples and the ratio of the area of ​​the diseased area of ​​the foot; Calculating the first treatment control coefficient; The second treatment control coefficient is obtained by calculating the pressure coefficient of the affected area and the area ratio of the affected area of ​​the foot; Calculating the second treatment control coefficient; The third treatment control coefficient is obtained by calculating the oxygen enrichment coefficient of the affected area and the area ratio of the affected area of ​​the foot; Calculate the third treatment control coefficient; The first treatment control coefficient, the second treatment control coefficient and the third treatment control coefficient are defined as diseased foot treatment analysis data.

9. The diabetic foot treatment device according to claim 1, characterized in that: The treatment control module automatically controls the diabetic foot treatment device, as follows: Acquire diseased foot treatment analysis data, and acquire a first treatment control coefficient, a second treatment control coefficient, and a third treatment control coefficient according to the diseased foot treatment analysis data; respectively obtaining a first treatment control coefficient threshold, a second treatment control coefficient threshold, and a third treatment control coefficient threshold; The first treatment control coefficient threshold, the second treatment control coefficient threshold and the third treatment control coefficient threshold are numerically compared with the first treatment control coefficient, the second treatment control coefficient and the third treatment control coefficient respectively, and the diabetic foot treatment device is automatically controlled according to the numerical comparison results.

10. A diabetic foot treatment device according to claim 9, characterized in that: The numerical comparison process is as follows: When the first treatment control coefficient is greater than or equal to the first treatment control coefficient threshold, the diabetic foot treatment instrument is controlled to start the ultraviolet treatment function; When the first treatment control coefficient is less than the first treatment control coefficient threshold, the diabetic foot treatment instrument is controlled to turn off the ultraviolet treatment function; When the second treatment control coefficient is greater than or equal to the second treatment control coefficient threshold, the diabetic foot treatment instrument is controlled to start the negative pressure treatment function; When the second treatment control coefficient is less than the second treatment control coefficient threshold, the diabetic foot treatment instrument is controlled to turn off the negative pressure treatment function; When the third treatment control coefficient is greater than or equal to the third treatment control coefficient threshold, the diabetic foot treatment instrument is controlled to start the oxygen enrichment treatment function; When the third treatment control coefficient is less than the third treatment control coefficient threshold, the diabetic foot treatment instrument is controlled to turn off the oxygen enrichment treatment function.

Images